Merck, maker of the cervical cancer vaccine Gardasil, is backing off its lobbying campaign following pressure from medical groups and parents who believe the vaccine should not be mandated as a school attendance requirement for adolescent girls.

The public outcry that caused Merck to announce its stop order on Tuesday stems from the fact that the vaccine protects against the sexually transmitted human papilloma virus (HPV), which causes cervical cancer. School-mandated vaccines are typically for diseases spread through casual contact, such as measles and mumps.

Merck's medical director for vaccines, Dr. Richard M. Haupt says, "We're concerned that our role in supporting school requirements is a distraction from that goal, and as such have suspended our lobbying efforts," adding that the company will continue providing information about the vaccine upon request.

Gardasil, launched in June and the first vaccine to prevent cervical cancer, has inspired controversy since day one. There's the cost -- $360 for three required shots -- and all sorts of insurance concerns and conservative groups who worry the vaccine encourages premarital sex and interferes with parental rights. Even those in support of the vaccine -- like the American Academy of Pediatrics and the American Academy of Family Practitioners -- question Merck's quick push to market this drug, especially in light of the company's withdrawn painkiller Vioxx.

"I believe that their timing was a little bit premature so soon after (Gardasil's) release, before we have a picture of whether there are going to be any untoward side effects," says Dr. Anne Francis, who chairs an American Academy of Pediatrics committee.

Legislatures in 20 states have taken steps to mandate the vaccine for young girls. And with the exception of Texas governor Rick Perry's February 2 executive order requiring Texas girls entering the sixth grade in 2008 get vaccinated, nothing has been made official so far.

The United Arab Emirates (UAE) is the first country in the Middle East to acquire the cervical cancer vaccine, Gardasil.

Comparisons of cervical cancer statistics for the years 1998 through 2005 show incidences of the disease tripling during this span of time. So acquisition of the vaccine is a true blessing for the women of this country.

"We are proud to have placed the UAE on the map with leading countries such as the US, Australia and EU by approving Gardasil, the first breakthrough vaccine that prevents the cancer," said Dr Wisam Haddadin, Franchise Manager, Gulf Region, Merck Sharp & Dohme.

Gardasil, distributed by Merck, Sharp, & Dohme, is now available in more than 33 countries for the prevention of cervical cancer, most commonly caused by HPV (human papilloma virus). About 2.3 million women are currently diagnosed with cervical cancer worldwide. About 800 women die of the disease every day.

A thirteen year old London girl has become the first in the country to receive the cervical cancer vaccine. The vaccine, Gardasil, launched in Britain last week, protects against the main viruses that cause cervical cancer. Gardasil targets the human papilloma viruses (HPV), which can be transmitted through sex.

Hollie Anderson's mother, Lisa, had the vaccine given to her daughter privately after seeing her own mother battle against cancer. She did this because the government has not yet issued a guidance on which groups will be routinely immunized. Mothers are taking their daughters to private clinics instead to get the vaccination. Dr. George Kassianos, the Royal College of General Practioners' immunization spokesman said: "This vaccine is available on prescription today, but patients should wait for the Department of Health to give us guidance. Everyone agrees that this is a great leap forward. I would ask that department to fast track a decision".

There are 2,800 new cases of cervical cancer diagnosed in Britain every year. About 1,000 women will die of the disease. Mrs. Anderson said "When I found out from our doctor that these injections were becoming available it wasn't a difficult decision to make" I asked Hollie and she said she wanted it. it was her decision. Afterwards she said 'Thank you mum, I know you're protecting me against a disease'.

The vaccine for cervical cancer was approved by the Food and Drug Administration in June for the use in girls and women and has been hailed as a breakthrough in cancer prevention. The vaccine prevents infections from some strains of the sexually transmitted human papilloma virus (HPV), which can cause cervical cancer.

Michigan girls entering the sixth grade next year would have to be vaccinated against cervical cancer, this would be a first of its kind of legislation for the United States.

The American Cancer Society estimates 9,700 women nationwide will be diagnosed with cervical cancer in 2006, and 3,700 will die.

Some say that making the vaccine mandatory infringes on parents' rights and encourages teen sex.

What do you think? Should the vaccine be mandatory or should the parents be able to decide?

The Human Papilloma Virus (HPV) can cause cervical cancer. The HIV drug called lopinavir attacks the HPV virus that causes cervical cancer. The University of Manchester team said that a cream can be made to apply directly to the cervix to kill the HPV virus.

There are cervical cancer vaccines being developed but if you already have the HPV virus then the vaccines won't be of any good. Most women that know they have HPV have to get regular Pap smears to test for abnormal cells in their cervix. Since we know that HPV can lead to cervical cancer it is watched closely. This cream if developed can lower the amount of surgeries to be performed on patients with abnormal Pap smears. The doctors would be able to use the cream to kill the HPV virus before it starts to cause malignant changes in the cells of the cervix.

The article also states that since the drug is already approved or treating HIV it might only take a few years for the drug to be available.

The Gay and Lesbian Medical Association, (GLMA) researches and publishes facts that life habits and practices in gay males may make them more susceptible to cancer, heart disease, and other serious health problems. The GLMA works to ensure equality in health care for lesbian, gay, bisexual and transgender (LGBT) individuals and health care professionals.

Studies show that gay men use tobacco at much higher rates than straight men. Some studies show that statistic is almost 50 percent higher in gays than straight males. Tobacco-related health problems include lung disease and lung cancer, heart disease, high blood pressure, and more serious problems. Studies also show that gay men have higher rates of alcohol dependence and abuse than straight men and the use of substances like amyl nitrate poppers, marijuana, Ecstasy, and amphetamines which could cause serious consequences as they age are more prevalent in gay men. Alcohol consumption and smoking are also related to bladder cancers, colon cancers and others.

Some health professionals now recommend routine screening with anal Pap Smears, similar to the test done for women to detect early cancers. Gay men are at risk for, human papilloma virus, (HPV), that cause anal and genital warts. These infections play a role in the increased rates of anal and oral cancers in gay men.

Having the freedom and courage to discuss your lifestyle openly with your medical doctor is a must. Once that patient - professional relationship has comfortably been made, discussing these health concerns is the first step to maintaining your health.

That there is an effective cervical cancer vaccine about to hit the market is encouraging news. Any successful and safe cancer prevention method is good news. Recently, a public service announcement, PSA, has been airing on television attempting to raise awareness about the virus that can lead to cervical cancer. The PSA I am seeing is coming from Merck, one of the drug companies that will be selling the vaccine. Unless I am mistaken, not once does the PSA mention the vaccine -- only the virus associated with cervical cancer. I believe this is intentional. I believe the drug company might be anticipating a resistance from the parents of teenage daughters to the vaccine based on ethical and moral grounds. If I were a drug company, I would quickly and reasonably decide to try to keep the vaccine above the fray of ethical and moral objections by promoting education about the virus.

Vaccines are a preventative measure against virus, not a treatment for after-exposure to a virus. As such, the ideal population to reach with a cervical cancer vaccine that protects against the sexually-transmitted human papilloma virus, HPV, will be teenage girls before they become sexually active. I predict it is going to be a controversial issue and debate where sexual activity of teenage girls becomes the focal point and not the potentially life-saving cancer prevention vaccine. I am betting the current awareness-raising ad campaign from the drug company in the virus link to cervical cancer is an attempt to minimize the debate with an educational approach. That's my hunch.